What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.
作者信息
Hurst J R, Wedzicha J A
机构信息
Academic Unit of Respiratory Medicine, Royal Free & University College Medical School, Rowland Hill Street, London NW3 2PF, UK.
出版信息
Thorax. 2007 Mar;62(3):198-9. doi: 10.1136/thx.2007.077883.
Abstract
Definition of what is (and what is not) a COPD exacerbation
摘要
相似文献
1
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.
Thorax. 2007 Mar;62(3):198-9. doi: 10.1136/thx.2007.077883.
2
Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary disease.
Pharmacotherapy. 2006 Sep;26(9 Pt 2):156S-63S. doi: 10.1592/phco.26.9part2.156S.
3
Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation.
Acad Emerg Med. 2007 Jan;14(1):6-14. doi: 10.1197/j.aem.2006.07.034. Epub 2006 Nov 21.
4
Exacerbation of chronic obstructive pulmonary disease.
Med J Malaysia. 2009 Sep;64(3):250-5; quiz 256.
5
How should we manage an acute exacerbation of COPD?
J Fam Pract. 2003 Oct;52(10):780-2.
6
Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders.
Prev Med. 2005 Mar;40(3):274-7. doi: 10.1016/j.ypmed.2004.06.010.
7
Treatment of acute exacerbation of COPD.
J Assoc Physicians India. 2012 Feb;60 Suppl:38-43.
8
[End therapeutic nihilism towards COPD].
MMW Fortschr Med. 2007 Mar 15;149(11):34-5, 37.
9
A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.
Int J Clin Pract. 2008 Aug;62(8):1219-36. doi: 10.1111/j.1742-1241.2008.01807.x. Epub 2008 Jun 28.
10
The 2007 GOLD Guidelines: a comprehensive care framework.
Respir Care. 2009 Aug;54(8):1040-9.
引用本文的文献
1
The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease.
Cureus. 2022 Dec 1;14(12):e32116. doi: 10.7759/cureus.32116. eCollection 2022 Dec.
2
[Validation study of MEP questionnaire for simplified detection of exacerbation of chronic obstructive pulmonary disease].
Pneumologie. 2022 Oct;76(10):671-678. doi: 10.1055/a-1925-7281. Epub 2022 Oct 18.
3
Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.
BMC Pulm Med. 2022 May 13;22(1):194. doi: 10.1186/s12890-022-01958-4.
4
The Effectiveness of Traditional Chinese Medicine (TCM) as an Adjunct Treatment on Stable COPD Patients: A Systematic Review and Meta-Analysis.
Evid Based Complement Alternat Med. 2021 Jun 4;2021:5550332. doi: 10.1155/2021/5550332. eCollection 2021.
5
Longitudinal Relationship Between Growth Differentiation Factor 11 and Physical Activity in Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2021 Apr 15;16:999-1006. doi: 10.2147/COPD.S301690. eCollection 2021.
6
Day-to-Day Variability of Parameters Recorded by Home Noninvasive Positive Pressure Ventilation for Detection of Severe Acute Exacerbations in COPD.
Int J Chron Obstruct Pulmon Dis. 2021 Mar 22;16:727-737. doi: 10.2147/COPD.S299819. eCollection 2021.
7
Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2020 Jun 19;15:1449-1464. doi: 10.2147/COPD.S245842. eCollection 2020.
8
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice - Results of the Non-Interventional DETECT Study.
Int J Chron Obstruct Pulmon Dis. 2020 Jun 10;15:1335-1347. doi: 10.2147/COPD.S252354. eCollection 2020.
9
Shufeng Jiedu capsules for treating acute exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
BMC Complement Med Ther. 2020 May 24;20(1):151. doi: 10.1186/s12906-020-02924-5.
10
Technology-Enabled Self-Monitoring of Chronic Obstructive Pulmonary Disease With or Without Asynchronous Remote Monitoring: Protocol for a Randomized Controlled Trial.
JMIR Res Protoc. 2019 Aug 19;8(8):e13920. doi: 10.2196/13920.
本文引用的文献
1
Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2006 Oct 15;174(8):867-74. doi: 10.1164/rccm.200604-506OC. Epub 2006 Jun 23.
2
COPD exacerbations . 3: Pathophysiology.
Thorax. 2006 Apr;61(4):354-61. doi: 10.1136/thx.2005.041830.
3
COPD exacerbations . 2: aetiology.
Thorax. 2006 Mar;61(3):250-8. doi: 10.1136/thx.2005.041822.
4
COPD exacerbations .1: Epidemiology.
Thorax. 2006 Feb;61(2):164-8. doi: 10.1136/thx.2005.041806.
5
Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2006 Jan 1;173(1):71-8. doi: 10.1164/rccm.200505-704OC. Epub 2005 Sep 22.
6
Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.
Ann Intern Med. 2005 Sep 6;143(5):317-26. doi: 10.7326/0003-4819-143-5-200509060-00007.
7
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Thorax. 2005 Nov;60(11):925-31. doi: 10.1136/thx.2005.040527. Epub 2005 Jul 29.
8
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
Thorax. 2004 Jul;59(7):574-80. doi: 10.1136/thx.2003.019588.
9
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2.
10
The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Am J Respir Crit Care Med. 2002 Jun 15;165(12):1592-6. doi: 10.1164/rccm.2105025.
Zotero 插件